Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease

Journal of Neuro-Ophthalmology

Volumn 33, Issue 2, 2013, Pages 137-142

  Adam, Christopher R ^a   Shrier, Eric ^a,c   Ding, Yin ^d   Glazman, Sofya ^b   Bodis Wollner, Ivan ^b,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Downstate Health Sciences University   (United States)

^c SUNY EYE INSTITUTE   (United States)

^d POLYTECHNIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST SENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MALE; NERVE CELL; PARKINSON DISEASE; PRIORITY JOURNAL; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; SCORING SYSTEM; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

AGED; ANALYSIS OF VARIANCE; CONTRAST SENSITIVITY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PERCEPTUAL DISORDERS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84879937435     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e31828c4e1a     Document Type: Article

References (44)

1. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14:223-236; discussion 222.
2. de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, Hofman A. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 1995;45:2143-2146.
3. Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, Oertel WH. Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a doorto-door survey of inhabitants older than 65 years. Arch Neurol. 1995;52:1017-1022.
4. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord. 2001;16:507-510.
5. Rodnitzky RL. Visual dysfunction in Parkinson's disease. Clin Neurosci. 1998;5:102-106.
6. Mestre D, Blin O, Serratrice G, Pailhous J. Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease. Neurology. 1990;40:1710-1714.
7. Bodis-Wollner I, Yahr MD. Measurements of visual evoked potentials in Parkinson's disease. Brain. 1978;101: 661-671.
8. Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol. 1996;100:1-11.
9. Pieri V, Diederich NJ, Raman R, Goetz CG. Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci. 2000;172:7-11.
10. Hajee ME, March WF, Lazzaro DR, Wolnitz AH, Shier EM, Glazman S, Bodis-Wollner IG. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol. 2009;127:737-741.
11. Valenti DA. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography. Neurology. 2007;69:1060.
12. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology. 2007;69:2085-2092.
13. Schutte M, Witkovsky P. Dopaminergic interplexiform cells and centrifugal fibres in the Xenopus retina. J Neurocytol. 1991;20:195-207.
14. Djamgoz MB, Hankins MW, Hirano J, Archer SN. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 1997;37:3509-3529.
15. Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci. 1990;31:2473-2475.
16. Ikeda H, Head GM, Ellis CJK. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res. 1994;34:2629-2638.
17. Witkovsky P. Dopamine and retinal function. Doc Ophthalmol. 2004;108:17-40.
18. Wink B, Harris J. A model of the parkinsonian visual system: support for the dark adaptation hypothesis. Vision Res. 2000;40:1937-1946.
19. Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA. Spatial frequency dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain. 1988;111:131-149.
20. Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain. 1987;110:1675-1698.
21. Watson AB. Gain, noise, and contrast sensitivity of linear visual neurons. Vis Neurosci. 1990;4:147-157.
22. Bodis-Wollner I, Spund B, Liu T, Shrier E, Selesnick I, Glazman S, Sohail N, Lazzaro D. Remodeling of the fovea in Parkinson disease. Invest Ophthalmol Vis Sci. 2011; 52:6660.
23. Alamouti B, Funk J. Retinal thickness decreases with age: an OCT study. Br J Ophthalmol. 2003;87:899-901.
24. Eriksson U, Alm A. Macular thickness decreases with age in normal eyes: a study on the macular thickness map protocol in the Stratus OCT. Br J Ophthalmol. 2009;93:1448-1452.
25. Crassini B, Brown B, Bowman K. Age-related changes in contrast sensitivity in central and peripheral retina. Perception. 1988;17:315-332.
26. Derefeldt G, Lennerstrand G, Lundh B. Age variations in normal human contrast sensitivity. Acta Ophthalmol (Copenh). 1979;57:679-690.
27. Elliott DB. Contrast sensitivity decline with ageing: a neural or optical phenomenon? Ophthalmic Physiol Opt. 1987;7:415-419.
28. Ross JE, Clarke DD, Bron AJ. Effect of age on contrast sensitivity function: uniocular and binocular findings. Br J Ophthalmol. 1985;69:51-56.
29. Knight OJ, Girkin CA, Budenz DL, Durbin MK, Feuer WJ. Effect of race, age, and axial length on optic nerve head parameters and retinal nerve fiber layer thickness measured by Cirrus HDOCT. Arch Ophthalmol. 2012;130:312-318.
30. Gao H, Hollyfield JG. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:1-17.
31. Harman A, Abrahams B, Moore S, Hoskins R. Neuronal density in the human retinal ganglion cell layer from 16-77 years. Anat Rec. 2000;260:124-131.
32. Jonas JB, Schmidt AM, Muller-Bergh JA, Schlotzer-Schrehardt UM, Naumann GO. Human optic nerve fiber count and optic disc size. Invest Ophthalmol Vis Sci. 1992;33:2012-2018.
33. Leung CK, Yu M, Weinreb RN, Ye C, Liu S, Lai G, Lam DS. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age-related loss. Ophthalmology. 2012;119:731-737.
34. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004;44:2793-2797.
35. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinsons Disease. Doc Ophthalmol. 2008;1116:137-146.
36. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010;4:1427-1432.
37. La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione G, Capellari S, Bonazza S, Giannoccaro MP, Calandra-Buonaura G, Liguior R, Cortelli P, Martinelli P, Barruzi A, Catelli V. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol. 2013;20:198-201.
38. Bodis-Wollner I, Spund B, Liu T, Shrier EM, Javaid M, Glazman S. Remodeling of the fovea in Parkinson disease. Invest Ophthalmol Vis Sci. 2011;52:e-abstract 6660.
39. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 2011;21:24-29.
40. Reader TA, Quesney LF. Dopamine in the visual cortex of the cat. Experientia. 1986;42:1242-1244.
41. Regan D, Maxner C. Orientation-selective visual loss in patients with Parkinson's disease. Brain. 1987;110:415-432.
42. Shrier E, Adam C, Spund B, Glazman S, Bodis-Wollner I. Intraocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol. 2012;2012:728457.
43. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990;13:296-302.
44. Bodis-Wollner I. Retinopathy in Parkinson disease. J Neural Transm. 2009;116:1493-1501.